BBI-4000 gel, 5%
Sponsors
Botanix Pharmaceuticals
Conditions
Hyperhidrosis
Phase 2
A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
CompletedNCT02336503
Start: 2015-03-10End: 2015-11-05Updated: 2023-03-15
A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
CompletedNCT03024255
Start: 2016-12-22End: 2017-09-19Updated: 2023-05-16